Ep. 301: “Cell Fate Decisions in Cancer” Featuring Dr. Mark Hatley
Update: 2025-08-05
Description
Dr. Mark Hatley is an Associate Faculty Member and Director of the Division of Molecular Oncology at St. Jude Children's Research Hospital. His research focuses on the developmental origins and genetic mechanisms of pediatric rhabdomyosarcoma. He talks about his work on pediatric oncology and the mechanisms that differentiate normal development from cancer. He also discusses the role of PAX3-FOXO1 and DICER1 in tumorigenesis.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
